financetom
Business
financetom
/
Business
/
Govt amends Differential Voting Rights provisions to boost start-ups
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Govt amends Differential Voting Rights provisions to boost start-ups
Aug 16, 2019 9:54 AM

The government has relaxed norms for shares with differential voting rights that will help companies retain control while raising equity capital. According to the ministry, the initiatives have been taken in response to requests from innovative technology companies and start-ups.

With the amended rules, companies can now have up to 74 per cent Differential Voting Rights (DVR) shares of the total post issue paid up share capital. The limit was earlier only 26 per cent.

The Corporate Affairs Ministry has amended the Companies (Share Capital & Debentures) Rules under the Companies Act.

"Another key change brought about is the removal of the earlier requirement of distributable profits for 3 years for a company to be eligible to issue shares with DVRs," the ministry said in a release on Friday.

It would also "strengthen the hands of Indian companies and their promoters who have lately been identified by deep pocketed investors worldwide for acquisition of controlling stake in them to gain access to the cutting edge innovation and technology development being undertaken by them," the ministry said.

Further, the ministry noted such Indian promoters have had to cede control of companies that have prospects of becoming Unicorns due to the requirements of raising capital through issuance of equity to foreign investors.

Generally, unicorns are start-ups that have a market valuation of at least USD 1 billion.

With respect to shares with DVRs, the existing cap of 26 per cent of the total post issue paid up equity share capital has been enhanced to 74 per cent.

Besides, Employee Stock Options (ESOPs) can now be issued by start-ups to promoters or directors holding more than 10 per cent of equity shares for 10 years from the date of their incorporation. The time period for such ESOPs was five years earlier.

The norms for shares with DVRs have been amended to enable promoters of Indian companies to retain control "in their pursuit for growth and creation of long term value for shareholders, even as they raise equity capital from global investors", the release said.

With inputs from agencies

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ExchangeRight All-Cash 14 DST Fully Subscribed, Expanding Essential Income REIT Pipeline
ExchangeRight All-Cash 14 DST Fully Subscribed, Expanding Essential Income REIT Pipeline
Oct 7, 2025
PASADENA, Calif.--(BUSINESS WIRE)-- ExchangeRight has announced the full subscription of Net-Leased All-Cash 14 DST, adding to the growing acquisition pipeline for ExchangeRight’s Essential Income REIT. The $23.3 million debt-free portfolio of net-leased real estate, backed by tenants operating in necessity-based industries, provides investors with monthly distributions at a current rate of 5.20% covered entirely by in-place lease revenues. Net-Leased All-Cash...
Sector Update: Consumer
Sector Update: Consumer
Oct 7, 2025
03:15 PM EDT, 10/07/2025 (MT Newswires) -- Consumer stocks were mixed late Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.6% and the Consumer Discretionary Select Sector SPDR Fund (XLY) retreating 1.7%. Redbook US same-store sales rose by 5.8% from a year earlier in the week ended Oct. 4 after a 5.9% year-over-year increase in the...
Former FDA vaccine chief Peter Marks joins Eli Lilly
Former FDA vaccine chief Peter Marks joins Eli Lilly
Oct 7, 2025
Oct 7 (Reuters) - Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly ( LLY ), the drugmaker told Reuters on Tuesday. Marks will oversee molecule discovery and infectious diseases at Lilly Research Laboratories. Peter's expertise strengthens our abilities across multiple areas, both in our...
Former FDA vaccine chief Peter Marks joins Eli Lilly
Former FDA vaccine chief Peter Marks joins Eli Lilly
Oct 7, 2025
(Reuters) -Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly ( LLY ), the drugmaker told Reuters on Tuesday. Marks will oversee molecule discovery and infectious diseases at Lilly Research Laboratories. Peter's expertise strengthens our abilities across multiple areas, both in our existing portfolio and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved